Details for New Drug Application (NDA): 018700
✉ Email this page to a colleague
The generic ingredient in INOCOR is inamrinone lactate. There is one drug master file entry for this compound. Additional details are available on the inamrinone lactate profile page.
Summary for 018700
Tradename: | INOCOR |
Applicant: | Sanofi Aventis Us |
Ingredient: | inamrinone lactate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 5MG BASE/ML | ||||
Approval Date: | Jul 31, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018700
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | INOCOR | inamrinone lactate | INJECTABLE;INJECTION | 018700-001 | Jul 31, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription